| DNMDX | MERIX | DNMDX / MERIX | |
| Total Expense Ratio | 2.38 | 1.27 | 187% |
| Annual Report Gross Expense Ratio | 2.38 | 1.37 | 174% |
| Fund Existence | 17 years | 12 years | - |
| Gain YTD | 7.248 | 7.920 | 92% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 100000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 265M | 2.45B | 11% |
| Annual Yield % from dividends | 7.45 | 2.07 | 359% |
| Returns for 1 year | 7.61 | 7.42 | 103% |
| Returns for 3 years | 20.24 | 13.06 | 155% |
| Returns for 5 years | 11.42 | 12.46 | 92% |
| Returns for 10 years | 2.34 | 32.71 | 7% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PAIGX | 24.02 | 0.17 | +0.71% |
| T. Rowe Price International Value Eq Adv | |||
| PGLRX | 19.16 | 0.04 | +0.21% |
| Putnam Focused International Equity R | |||
| NDVBX | 16.11 | -0.01 | -0.06% |
| MFS New Discovery Value B | |||
| BUIOX | 16.85 | -0.08 | -0.47% |
| Buffalo Early Stage Growth Instl | |||
| ALOCX | 19.30 | -0.18 | -0.92% |
| Alger Mid Cap Focus C | |||